Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients

MAARET ESKELINEN; IINA SAIMANEN; RIIKA KOSKELA; ANU HOLOPAINEN; TUOMAS SELANDER; MATTI ESKELINEN

doi:10.21873/invivo.12764

Research ArticleClinical Studies

Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients

MAARET ESKELINEN, IINA SAIMANEN, RIIKA KOSKELA, ANU HOLOPAINEN, TUOMAS SELANDER and MATTI ESKELINEN

In Vivo March 2022, 36 (2) 773-779; DOI: https://doi.org/10.21873/invivo.12764

MAARET ESKELINEN

1Department of Surgery, Kuopio University Hospital and School of Medicine, University of Eastern Finland, Kuopio, Finland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: matti.eskelinen{at}kuh.fi

IINA SAIMANEN

1Department of Surgery, Kuopio University Hospital and School of Medicine, University of Eastern Finland, Kuopio, Finland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

RIIKA KOSKELA

2Department of Anaesthesiology and Intensive Care, Kuopio University Hospital, Kuopio, Finland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

ANU HOLOPAINEN

3Department of Clinical Chemistry, Eastern Finland Laboratory Center, Kuopio University Hospital, Kuopio, Finland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TUOMAS SELANDER

4Science Service Center, Kuopio University Hospital, Kuopio, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MATTI ESKELINEN

1Department of Surgery, Kuopio University Hospital and School of Medicine, University of Eastern Finland, Kuopio, Finland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Study flowchart.
Download figure
Open in new tab
Download powerpoint
Figure 2.
Plasma median 4-hydroxynonenal (4-HNE) concentrations in benign and cancer patients preoperatively, immediately after operation and 24 h after operation. p≤0.001 using the Wilcoxon signed-rank test.
Download figure
Open in new tab
Download powerpoint
Figure 3.
Plasma malonidialdehyde (MDA) concentrations versus plasma 4-hydroxynonenal (4-HNE) concentrations in benign and cancer patients shown as Jitterplot. Spearman’s r=0.413, p<0.001).

Tables

Figures

PreviousNext

In this issue

In Vivo

Vol. 36, Issue 2

March-April 2022

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients

Message Subject (Your Name) has sent you a message from In Vivo

Message Body (Your Name) thought you would like to see the In Vivo web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 8 + 1 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients

MAARET ESKELINEN, IINA SAIMANEN, RIIKA KOSKELA, ANU HOLOPAINEN, TUOMAS SELANDER, MATTI ESKELINEN

In Vivo Mar 2022, 36 (2) 773-779; DOI: 10.21873/invivo.12764

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients

MAARET ESKELINEN, IINA SAIMANEN, RIIKA KOSKELA, ANU HOLOPAINEN, TUOMAS SELANDER, MATTI ESKELINEN

In Vivo Mar 2022, 36 (2) 773-779; DOI: 10.21873/invivo.12764

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Targeting AASS improves neurotoxicity and mitochondrial function in astrocyte models for pyridoxine dependent epilepsy
Free Interleukin 18 (IL-18F) Blood Levels Following Midline Laparotomy: A Prospective Randomized Study of Patients With Benign Disease and Patients With Cancer
Brief Pain Inventory (BPI) Pain Survey Versus Cysteine Protease Caspase-1 (Casp1) Blood Levels Following Midline Laparotomy: A Prospective Randomized Study of Patients With Benign Disease and Patients With Cancer

Google Scholar

Keywords

Benign disease
cancer
lipid peroxidation
plasma 4-hydroxynonenal
pain score following surgery

Main menu

User menu

Search

Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords